Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVO

Novo Nordisk ADR

Feb 23 • 04:00PM ET

39.63

-7.79 -16.43 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Today, 5:30 AMDisappointing CagriSema trial results versus Eli Lilly's tirzepatide ignited premarket plunge.

Peers: LLY MRK ABBV JNJ AMGN AZN-D PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI WCMI PID PINK OZEM AQEC APIE

Scroll to Statements

Index	-	P/E	11.43	EPS (ttm)	3.47	Insider Own	0.02%	Shs Outstand	3.37B	Perf Week	-20.05%
Market Cap	133.52B	Forward P/E	11.48	EPS next Y	3.45	Insider Trans	0.00%	Shs Float	3.37B	Perf Month	-36.32%
Enterprise Value	149.87B	PEG	6.75	EPS next Q	0.81	Inst Own	9.44%	Short Float	0.94%	Perf Quarter	-19.12%
Income	15.45B	P/S	2.86	EPS this Y	-7.60%	Inst Trans	-0.10%	Short Ratio	1.49	Perf Half Y	-28.53%
Sales	46.77B	P/B	5.77	EPS next Y	2.71%	ROA	20.59%	Short Interest	31.69M	Perf YTD	-22.11%
Book/sh	6.87	P/C	31.49	EPS next 5Y	1.70%	ROE	61.25%	52W High	93.80 -57.75%	Perf Year	-55.01%
Cash/sh	1.26	P/FCF	14.92	EPS past 3/5Y	26.28% 20.36%	ROIC	31.38%	52W Low	43.08 -8.01%	Perf 3Y	-44.53%
Dividend Est.	1.69 (4.26%)	EV/EBITDA	6.63	Sales past 3/5Y	23.19% 19.21%	Gross Margin	80.90%	Volatility	2.22% 3.57%	Perf 5Y	10.57%
Dividend TTM	1.73 (4.36%)	EV/Sales	3.20	EPS Y/Y TTM	5.57%	Oper. Margin	41.17%	ATR (14)	2.56	Perf 10Y	52.63%
Dividend Ex-Date	Mar 30, 2026	Quick Ratio	0.57	Sales Y/Y TTM	11.11%	Profit Margin	33.03%	RSI (14)	26.24	Recom	2.26
Dividend Gr. 3/5Y	28.28% 20.66%	Current Ratio	0.80	EPS Q/Q	3.95%	SMA20	-23.29%	Beta	0.69	Target Price	57.03
Payout	38.07%	Debt/Eq	0.67	Sales Q/Q	0.66%	SMA50	-25.58%	Rel Volume	4.61	Prev Close	47.42
Employees	68794	LT Debt/Eq	0.61	Earnings	Feb 04 BMO	SMA200	-31.35%	Avg Volume	21.32M	Price	39.63
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.40% 3.10%	Trades		Volume	98,342,862	Change	-16.43%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Deutsche Bank	Buy → Hold
Feb-12-26	Upgrade	Jefferies	Underperform → Hold
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156

Show Previous Ratings

Today 05:33PM	Stocks to Watch Monday Recap: Diamondback, Netflix, Novo Nordisk, Lilly (The Wall Street Journal) -16.43%
05:17PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:01PM	Hims & Hers Health Fourth-Quarter Sales Rise, Gives Soft First-Quarter Guidance (The Wall Street Journal)
04:40PM	Stock Market Today: Dow Sinks As EU Makes Trump Tariff Move; IBM Dives On This AI Threat (Live Coverage) (Investor's Business Daily)
04:27PM	These Stocks Are Todays Movers: Novo Nordisk, Lilly, PayPal, Arcellx, CrowdStrike, KKR, Strategy, and More (Barrons.com)
04:25PM	Loading…
04:25PM	Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. (Barrons.com)
04:11PM	Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin (Investor's Business Daily)
03:32PM	Why Novo Nordisk Stock Is Plungingand Why Its Good News for Eli Lilly (Barrons.com)
03:20PM	Reliance Q4 Earnings Call Highlights (MarketBeat)
03:13PM	Stock Market Today: Dow Dives, Cybersecurity Plays Hit As Software Sinks; Gold Stocks Shine (Live Coverage) (Investor's Business Daily)
02:30PM	Nasdaq, Dow Jones start the week lower as Trump resets tariffs (Proactive)
02:29PM	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz (Benzinga)
02:03PM	Stock Market Today: Dow Skids As EU Makes Trump Tariff Move; These Gold Stocks Shine (Live Coverage) (Investor's Business Daily)
01:50PM	Stocks to Watch Monday: Merck, Netflix, Novo Nordisk, Eli Lilly (The Wall Street Journal)
01:10PM	Novo Nordisk Trips in the Obesity Race (Moby)
01:01PM	Loading…
01:01PM	Novo Nordisk Shares Drop 15% After CagriSema Misses Phase 3 Goal (GuruFocus.com)
12:57PM	Novo Nordisk shares sink after weight loss drug fails to match Eli Lilly's in trial (CNBC TV)
12:44PM	Novo Next-Generation Obesity Shot Falls Short of Lilly Rival (Bloomberg)
12:34PM	Stock Market Today: Dow Dives As EU Makes Trump Tariff Move; Novo Plunges On This (Live Coverage) (Investor's Business Daily)
11:55AM	Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out (Reuters)
11:44AM	Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound (The Wall Street Journal)
11:42AM	Novo Nordisk's Loss Is Eli Lilly's Gain (Benzinga)
11:35AM	Novo Nordisk Tumbles in 'Worst Case Scenario': Next-Gen Weight Loss Drug Underperforms (Benzinga)
11:32AM	Stock Of The Day: Breakdown In Novo Nordisk? (Benzinga)
11:15AM	Trump puts pressure on Netflix board, Domino's stock rises on Q4 (Yahoo Finance Video)
11:10AM	Novo Nordisk Sinks, Lilly Surges After Obesity Drug Trial Shock (GuruFocus.com)
11:08AM	Novo Nordisk Stock Tumbles Monday to Its Lowest Point in Nearly 5 Years. Here's Why (Investopedia)
10:35AM	Novo Nordisk Stock Suffers After Weight Loss Drug Underperformance (Schaeffer's Research)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:56AM	Dr. Scott Gottlieb: Tariffs are a very inefficient tool to reshore drug manufacturing (CNBC TV)
09:53AM	Loading…
09:53AM	Stock Market Today: Dow Up After New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
09:41AM	Stocks to Watch Monday: Novo Nordisk, Merck, Domino's, Gilead (The Wall Street Journal)
09:36AM	Why Novo Nordisk Stock Is Pluging-and Why It's Good News for Lilly (Barrons.com)
09:30AM	Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say (Reuters)
09:11AM	Weight-loss drug trial results wipe £147bn off Ozempic maker (The Telegraph)
09:03AM	Lilly to launch multi-dose weight-loss drug device in US (Reuters)
09:00AM	Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know (Zacks)
08:46AM	Stock Market Today: Dow Falls On New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
08:41AM	Novo Nordisk's CagriSema falls short against Eli Lilly's in trial (Reuters Videos)
08:11AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:09AM	Novo Nordisk's next obesity drug falls short of Lilly rival, wiping billions off its market value (Proactive)
07:39AM	Novo Nordisk flags board members for re-election amid restructuring efforts (Pharmaceutical Technology)
07:04AM	Premarket movers: Novo Nordisk, Eli Lilly, Domino's Pizza and more (MarketWatch)
06:32AM	Novo Nordisk Stock Plunges and Eli Lilly Jumps. It's All Down to This Weight-Loss Drug Trial. (Barrons.com)
05:58AM	These Stocks Are Today's Movers: Novo Nordisk, Eli Lilly, Paramount, Nvidia, and More (Barrons.com)
05:33AM	Stock Market Today: Dow Jones, S&P 500 Futures Drop After Supreme Court Strikes Down Trump's Emergency Tariffs- Novo Nordisk, Strategy, Vanda In Focus (Benzinga)
05:31AM	Novo Nordisk Stock Hits 52-Week Low After Weight-Loss Drug Falls Short Against Eli Lilly's (Benzinga)
05:07AM	Novo Nordisk pitted a new weight-loss drug against Eli Lilly - and lost (MarketWatch)
03:19AM	Stock Market Today: Dow set for 200-point retreat, S&P 500 and Nasdaq to slide after Trump hikes global tariffs to 15% (MarketWatch)
Feb-22-26 02:00PM	2 'vanity' stock picks & 1 crypto play this strategist loves (Yahoo Finance Video)
05:03AM	GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies (USA TODAY)
Feb-21-26 10:03AM	Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside (MarketBeat)
Feb-20-26 11:27AM	Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus (Zacks)
08:30AM	Prothena Corporation plc Q4 2025 Earnings Call Summary (Moby)
Feb-19-26 07:08PM	Prothena Q4 Earnings Call Highlights (MarketBeat)
02:55PM	Hims & Hers to Buy Australian Telehealth Provider Eucalyptus in $1.15 Billion Deal (Barrons.com)
02:03PM	Novo Nordisk Cuts 5,000 Jobs as Denmark Unemployment Hits 3.0% (GuruFocus.com)
01:04PM	Hims & Hers to acquire Australian digital health firm Eucalyptus, expanding international footprint (Proactive)
10:13AM	Hims & Hers Agrees To Buy Eucalyptus In $1.15 Bil Deal. Stock Rallies. (Investor's Business Daily)
08:50AM	Hims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams (Benzinga)
08:08AM	Hims & Hers is spending more than $1 billion in a push to expand globally (MarketWatch)
07:25AM	Hims & Hers Stock Jumps on $1.15 Billion Deal to Acquire Australian Telehealth Provider (Barrons.com)
07:04AM	Hims & Hers Q4 Earnings Preview: What To Expect From Upcoming Report (GuruFocus.com)
Feb-18-26 11:01AM	Novo expands injectable Wegovy offering with European higher dose approval (Pharmaceutical Technology)
09:41AM	EU Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients (Zacks)
07:22AM	Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition? (Zacks)
Feb-17-26 05:12PM	Eli Lilly Preps Oral Weight-Loss Launch (GuruFocus.com)
11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
09:39AM	Novo Nordisks Wegovy Weight Loss Shot Approved at Higher Dose in EU (The Wall Street Journal)
08:59AM	Eli Lilly Stock Rises as $1.5 Billion Weight-Loss Pill Prepares to Hit Market (GuruFocus.com)
08:37AM	Eli Lilly Targets India as Global Export Hub Amid Surging Mounjaro Sales (GuruFocus.com)
Feb-16-26 02:00PM	Why Eli Lillys $1 Billion AI Bet Could Reshape Drug Discovery (24/7 Wall St.)
11:19AM	Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Months 48% Selloff (24/7 Wall St.)
10:26AM	NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock? (Zacks)
09:54AM	Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? (Zacks)
Feb-14-26 05:30AM	How Ozempic Brought a Napster Moment to Big Pharma (The Wall Street Journal)
Feb-13-26 02:08PM	Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit (GuruFocus.com)
12:59PM	Eli Lilly Builds $1.5 Billion Pill Inventory (GuruFocus.com)
12:24PM	Eli Lilly Builds Orforglipron Inventory Ahead of FDA Review (GuruFocus.com)
10:20AM	Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure (CNBC TV)
06:21AM	Analysis-US could take action including fines against Hims after brief Wegovy copy launch (Reuters)
05:36AM	Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms (Benzinga)
Feb-12-26 01:14PM	Novo Nordisk plans Wegovy vials amid obesity-drug competition (Proactive)
01:02PM	Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market (Benzinga)
08:42AM	How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report (Zacks)
08:03AM	VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates (Zacks)
08:02AM	McDonald's gears up to battle GLP-1 weight-loss drug pills (Yahoo Finance)
08:02AM	'We know that consumers' behavior changes': McDonald's prepares for wider GLP-1 adoption as weight-loss pills hit market (Yahoo Finance)
07:28AM	Jefferies lifts Novo Nordisk rating as downside risks crystallize (Investing.com)
04:23AM	Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs (Benzinga)
Feb-11-26 09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
08:59AM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
08:45AM	Novo Nordisk target cut by Deutsche Bank despite long-term optimism (Proactive)
06:46AM	Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning (Benzinga)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
04:01PM	Gilead's Earnings Surprise. HIV Drug Sales Were Strong. (Barrons.com)
03:48PM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
03:08PM	Why cheaper GLP-1 drugs are facing legal battles (CNBC TV)
10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
10:23AM	Novo Nordisk opens new front with patent suit over Hims Wegovy copies (Reuters Videos)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience